Renaissance Technologies’s Core Laboratories CLB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $850K | Sell |
50,603
-132,797
| -72% | -$2.38M | ﹤0.01% | 2350 |
|
|
2025
Q4 | $2.94M | Buy |
183,400
+149,219
| +437% | +$2.22M | ﹤0.01% | 1636 |
|
|
2025
Q3 | $422K | Buy |
+34,181
| New | +$401K | ﹤0.01% | 2866 |
|
|
2024
Q4 | – | Sell |
-27,600
| Closed | -$511K | – | 3607 |
|
|
2024
Q3 | $511K | Buy |
+27,600
| New | +$554K | ﹤0.01% | 2783 |
|
|
2024
Q2 | – | Sell |
-46,300
| Closed | -$791K | – | 3543 |
|
|
2024
Q1 | $791K | Buy |
+46,300
| New | +$728K | ﹤0.01% | 2635 |
|
|
2023
Q1 | – | Sell |
-17,000
| Closed | -$345K | – | 4015 |
|
|
2022
Q4 | $345K | Buy |
+17,000
| New | +$330K | ﹤0.01% | 3162 |
|
|
2022
Q2 | – | Sell |
-138,100
| Closed | -$4.37M | – | 4255 |
|
|
2022
Q1 | $4.37M | Buy |
138,100
+41,833
| +43% | +$1.17M | 0.01% | 1697 |
|
|
2021
Q4 | $2.15M | Buy |
+96,267
| New | +$2.51M | ﹤0.01% | 2090 |
|
|
2021
Q2 | – | Sell |
-23,289
| Closed | -$670K | – | 3488 |
|
|
2021
Q1 | $670K | Sell |
23,289
-58,113
| -71% | -$1.99M | ﹤0.01% | 2791 |
|
|
2020
Q4 | $2.16M | Sell |
81,402
-54,691
| -40% | -$1.12M | ﹤0.01% | 2078 |
|
|
2020
Q3 | $2.08M | Sell |
136,093
-198,355
| -59% | -$4.16M | ﹤0.01% | 2105 |
|
|
2020
Q2 | $6.8M | Sell |
334,448
-315,552
| -49% | -$5.66M | 0.01% | 1454 |
|
|
2020
Q1 | $6.72M | Buy |
+650,000
| New | +$18.2M | 0.01% | 1394 |
|
|
2019
Q2 | – | Sell |
-250,700
| Closed | -$17.3M | – | 3561 |
|
|
2019
Q1 | $17.3M | Sell |
250,700
-186,600
| -43% | -$12.5M | 0.02% | 1055 |
|
|
2018
Q4 | $26.1M | Buy |
437,300
+274,600
| +169% | +$23.7M | 0.03% | 736 |
|
|
2018
Q3 | $18.8M | Sell |
162,700
-121,400
| -43% | -$13.7M | 0.02% | 975 |
|
|
2018
Q2 | $35.9M | Buy |
284,100
+61,800
| +28% | +$7.52M | 0.04% | 588 |
|
|
2018
Q1 | $24.1M | Buy |
222,300
+152,100
| +217% | +$16.8M | 0.03% | 832 |
|
|
2017
Q4 | $7.69M | Buy |
+70,200
| New | +$7.01M | 0.01% | 1545 |
|
|
2017
Q3 | – | Sell |
-116,200
| Closed | -$11.8M | – | 3215 |
|
|
2017
Q2 | $11.8M | Sell |
116,200
-55,900
| -32% | -$6.03M | 0.02% | 1177 |
|
|
2017
Q1 | $19.9M | Buy |
+172,100
| New | +$20M | 0.03% | 806 |
|
|
2016
Q4 | – | Sell |
-221,900
| Closed | -$24.9M | – | 3263 |
|
|
2016
Q3 | $24.9M | Sell |
221,900
-19,400
| -8% | -$2.23M | 0.04% | 582 |
|
|
2016
Q2 | $29.9M | Buy |
+241,300
| New | +$29.1M | 0.06% | 459 |
|
|
2015
Q4 | – | Sell |
-106,600
| Closed | -$10.6M | – | 3288 |
|
|
2015
Q3 | $10.6M | Sell |
106,600
-149,540
| -58% | -$16.3M | 0.03% | 903 |
|
|
2015
Q2 | $29.2M | Sell |
256,140
-215,360
| -46% | -$26.1M | 0.07% | 361 |
|
|
2015
Q1 | $49.3M | Buy |
471,500
+325,500
| +223% | +$34.7M | 0.1% | 214 |
|
|
2014
Q4 | $17.6M | Buy |
146,000
+57,000
| +64% | +$7.49M | 0.04% | 578 |
|
|
2014
Q3 | $13M | Sell |
89,000
-82,800
| -48% | -$12.8M | 0.04% | 626 |
|
|
2014
Q2 | $28.7M | Buy |
171,800
+108,342
| +171% | +$19.3M | 0.07% | 332 |
|
|
2014
Q1 | $12.6M | Sell |
63,458
-85,842
| -57% | -$16.2M | 0.03% | 737 |
|
|
2013
Q4 | $28.5M | Sell |
149,300
-73,200
| -33% | -$13.6M | 0.07% | 348 |
|
|
2013
Q3 | $37.6M | Buy |
222,500
+5,000
| +2% | +$776K | 0.09% | 250 |
|
|
2013
Q2 | $33M | Buy |
+217,500
| New | +$30.8M | 0.09% | 279 |
|
Other funds holding CLB
AI
DGI
CAMG
VCM
VPM
Renaissance Technologies's CLB Position: Q1 2026 in Review
Renaissance Technologies reduced its Core Laboratories (CLB) stake by 72% in Q1 2026, selling an estimated $2.38M and leaving 50,603 shares worth $850K. The position accounts for ﹤0.01% of the portfolio, ranked #2350.
Renaissance Technologies first reported a position in CLB in Q2 2013 and has held it in 33 quarters since. The position peaked at $49.3M in Q1 2015. 190 funds tracked by Wall St. Rank hold CLB as of Q1 2026.
- Renaissance Technologies held 50,603 shares of Core Laboratories worth $850K as of Q1 2026.
- Renaissance Technologies sold 132,797 Core Laboratories shares in Q1 2026, an estimated $2.38M.
- Core Laboratories made up ﹤0.01% of Renaissance Technologies's portfolio in Q1 2026, its #2350 holding.
- Renaissance Technologies first reported a position in Core Laboratories in Q2 2013 and has held it in 33 quarters since.
- Renaissance Technologies's Core Laboratories position peaked at $49.3M in Q1 2015.
- 190 funds tracked by Wall St. Rank held Core Laboratories as of Q1 2026.
Based on Renaissance Technologies's 13F filing for Q1 2026, filed 14 May 2026.